Johnson & Johnson Asks FDA to Approve COVID-19 Vaccine Booster Doses
The booster is for those who already received the one-shot vaccine
Johnson & Johnson asked the Food and Drug Administration (FDA) on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.
J&J said it filed a request with the FDA to authorize boosters for people who previously received the company's one-shot vaccine. While the company said it submitted data on several different booster intervals, ranging from two to six months, it did not formally recommend one to regulators.
Last month, the FDA authorized booster shots of Pfizer's vaccine for older Americans and other groups with heightened vulnerability to COVID-19. It's part of a sweeping effort by the Biden administration to shore up protection amid the delta variant and potential waning vaccine immunity. Last week, President Biden received a booster shot on camera.
Please select this link to read the complete article from CBS News.